The WSJ Health Blog noted on Friday that Jan Marini Skin Research has released a new eyelash-enhancement product. Called Marini Lash, the product uses “an entirely new technology that yields phenomenal results,” according to the Health Blog. (Hat tip: Dennis Rogers.)

Marini’s original eyelash conditioner, introduced in 2005, was an instant hit with beauty-conscious consumers seeking longer, thicker lashes. The product, applied using a mascara-like wand, blurred the line between cosmetic and drug because it contained an ingredient similar to one found in Allergan’s glaucoma drug Lumigan. (See the images at right for the effects of Lumigan on one patient.)

The FDA claimed the Marini product was an “unapproved and misbranded drug.” In a lawsuit, drugmaker Allergan accused Marini of violating patents for so-called prostaglandins.

According to the company, the new product contains no prostaglandins.

One of our fascinations with aesthetic surgery is that, as we go along, we are constantly reinventing and revising traditions and approaches to procedures.

A recent study published in Plastic and Reconstructive Surgery found that when presented with candidate faces digitally altered to show simulated eyelid surgery effects, the surgery could make the patient look more tired and older-looking than before.

Absolutely fascinating.

The purpose of this Yale University-based study was, "to characterize the relative influence of eyebrow position and shape, lid position, and facial rhytides on perceived facial expression as related to blepharoplasty, with a specific focus on the perception of tiredness," according to the writers.

More...

A recent study shows that, as people age, their jaws grow and widen and "drop" -- research that may influence the ways in which facial augmentation is approached, according to physicians at the University of Texas (UT) Southwestern Medical Center, Dallas.

More...